Explainer: The FDA expands abortion pill access in local pharmacies

On Jan. 3, the Food and Drug Administration (FDA) issued a regulatory change that allows pharmacy chains and local pharmacies to distribute the first of the two-stage abortion pill regiment known as Mifepristone.

Why does this matter?
This change will have devastating and widespread effects on preborn children, their mothers, our communities, and likely many pharmacists in abortion-friendly states.

First, there are the obvious and deep concerns about ending the lives of the preborn and grav...